Specifications TableSubjectChemistrySpecific subject areaAnalytical Chemistry. Human Biomonitoring.Type of dataTables and figuresHow data were acquiredAgilent 7890C-7010 gas chromatography-triple quadrupole mass spectrometry system (GC-MS/MS) in the electron ionization mode (EI mode), and Agilent 7890A-5975C GC-MS working under electron capture negative ion chemical ionization (NCI) mode. The data acquisition was done by Agilent Masshunter Workstation.Data formatRaw and AnalyzedParameters for data collectionAn aliquot of sample (2 mL for serum samples, ∼5 g for lyophilized placenta) was spiked with TCMX as internal standards (50 ng, IS). 0.5 mL of formic acid, 2.5 mL of ethanol and 10 mL of n-hexane/DCM (1:1, v/v) was then added in for the extraction. The mixture was thoroughly mixed, ultrasonic extracted for ten minutes, followed by centrifugation separation at 2000 rpm for ten minutes. The organic phase was then collected; the ultrasonic extraction procedure was repeated three times. The extract was evaporated under vacuum to ∼1 mL, then cleaned up by column chromatography with pre-activated silica gel and Na~2~SO~4~. Targeted compounds were collected using another portion of 70 mL of n-hexane/DCM (1:1, v/v) elution. The elution was evaporated to near dryness in a GC sample bottle, then reconstituted in 50 μL of n-nonane. Total lipids (TL) in the serum was calculated: TL (g/l) = 1.12 × CHOL + 1.33 × TG + 1.48. The lipid weight of the placenta was determined gravimetrically.Description of data collectionMatched maternal serum, cord serum and placenta samples from 79 volunteer mothers and their infants were collected between November 2015 and March 2016 in Wuhan, China.\
Informed consent was given by all participants to collect the physical and sociodemographic data.\
Organochlorine pesticides (OCPs) concentrations were measured in the samples. Enantiomeric fractions were also determined for chiral OCPs in the samples.Data source locationYin, Shanshan; Zhang, Jianyun; Guo, Fangjie; Zhao, Lu; Poma, Giulia; Covaci, Adrian; Liu, Weiping (2019), "Data for: Transplacental Transfer of Organochlorine Pesticides: Concentration Ratio and Chiral Properties", Mendeley Data, V1 <https://doi.org/10.17632/dx6ffmm8zn.1>Data accessibilityThe data are given with the article and stored in Mendeley Data.Related research articleS. Yin, J. Zhang, F. Guo, L. Zhao, G. Poma, A. Covaci et al., Transplacental transfer of organochlorine pesticides: Concentration ratio and chiral properties, Environ Int. 130 (2019)\
[https://doi.org/10.1016/j.envint.2019.104939](10.1016/j.envint.2019.104939){#intref0015}.**Value of the Data**•The data in this article presents information on evaluation of pre-treatment, and data interpretation and correlation information for the OCPs in the maternal serum, cord serum and placenta in sampling population.•The data can provide the readers for understanding the transplacental efficiency and related mechanism for the OCPs in human.•The dataset was an expansion in the database of human biomonitoring data in maternal serum, cord serum and placenta in human, also could provide the reference data in the meta-analysis for the cross-membrane investigations.

1. Data {#sec1}
=======

The data reported here provided essential information for the article by Yin et al. [@bib1]. Raw data for [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"} were provided in Mendeley Data [@bib2].Table 1Matrix spiking recoveries (n = 3) at 3 different concentration levels and method detection (MDL) and quantitation limits (MQL) for targeted analytes in serum and placenta samples. The MDL and MQL were defined as the concentration that has 3 or 10 in the signal to noise ratio in the blank matrix.Table 1SerumAnalytesSpike recovery ± SD (%)MDLMQL20 ng mL^−1^5 ng mL^−1^0.5 ng mL^−1^(pg mL^−1^)(pg mL^−1^)α-HCH77.5±5.281.1±7.785.8±2.90.82.7β-HCH103±3.4106±1.596.3±4.83.110.4γ-HCH93.4±7.1102±6.1109±8.05.919.7δ-HCH90.8±2.888.8±4.5104±4.84.314.4*o,p'-*DDE87.3±6.395.6±7.588.3±2.40.62.2*p,p'-*DDE78.5±4.687.4±4.883.7±1.83.09.9*o,p'-*DDD92.1±6.1107±6.8104±7.40.72.5*p,p'-*DDD86.4±6.892.9±8.392.9±7.00.31.1*o,p'-*DDT96.8±3.285.5±7.685.1±2.50.41.2*p,p'-*DDT90.1±7.1110.6±4.7109±6.90.41.5TCMX[a](#tbl1fna){ref-type="table-fn"}96.3±3.7------------Placenta(pg g^−1^)(pg g^−1^)α-HCH74.3±5.297.6±2.684.3±6.54.113.6β-HCH86.6±3.4112±5.981.6±1.63.912.9γ-HCH96.6±7.1113±8.887.4±8.02.17.0δ-HCH99.6±2.8110±4.382.5±8.41.65.3*o,p'-*DDE106±6.387.6±5.496.9±3.71.13.6*p,p'-*DDE109±4.6110±4.785.9±5.815.351.1*o,p'-*DDD92.5±6.1109±7.291.6±7.81.23.9*p,p'-*DDD91.2±6.897.4±1.088.4±3.02.37.8*o,p'-*DDT75.6±3.280.4±3.486.0±7.11.03.4*p,p'-*DDT96.3±7.188.5±2.981.1±1.51.13.6TCMX[a](#tbl1fna){ref-type="table-fn"}94.9±6.8------------[^1]Table 2Detection frequency (DF%) and mean, median (50th percentile) and percentiles of the wet-weight basis concentrations of targeted analytes in maternal serum, cord serum (in ng ml^−1^) and placenta (in ng g^−1^ tissue weight). The concentrations higher than the MDL but lower than the MQL were represented as \< MQL in this table.Table 2AnalytesMaternal Serum (n = 52)Cord Serum (n = 70)Placenta (n = 57)DF (%)MeanSD255075DF (%)MeanSD255075DF (%)MeanSD255075α-HCH642011111726673.42.36\<MQL3.14.06100102336162972β-HCH72336701\<MQL844876172159\<MQL1495100185032401574471960γ-HCH9215041722.240101762784\<MQL81498663161058.7187486δ-HCH723415\<MQL34419374\<MQL6910037096896.2188285Total-HCHs1003658314010631710071166919551002980423052112003690*o,p\'-*DDE63935\<MQL2373210\<MQL2.38100336141735*p,p\'-*DDE10043434221433556490145121571131871004300664086423005870*o,p\'-*DDD5433\<MQL2530\<MQL1\<MQL\<MQL2.6914138113764*p,p\'-*DDD3522\<MQL\<MQL371\<MQL1.3\<MQL\<MQL1.4722440\<MQL1326.5*o,p\'-*DDT3932\<MQL2460\<MQL0.8\<MQL\<MQL0.86017294818*p,p\'-*DDT6532\<MQL246141\<MQL127235166\<MQL7.2813Total-DDXs10043234720831959096142125581101921004360679085624906010Fig. 1Box-plots with dots representing the lipid adjusted concentration ratio of DDX metabolites (DDD + DDE) *vs*. the DDT parent compounds. The ratio \>0.5 reflected historical use of DDT while \<0.5 indicated the recent exposure to DDT products. Each dot represents a sample. The box represents the 10th, 50th and 90th percentile of the value, the whiskers represent 5th and 95th. The scale of y-axis was log~10~-transformed.Fig. 1Fig. 2Box-plots with dots representing the lipid adjusted concentration ratio of β-HCH *vs*. (α+γ)-HCH. The ratio ≥0.5 reflected historical use of technical HCHs or lindane while \<0.5 indicated the recent exposure to lindane products. Each dot represents a sample. The box represents the 10th, 50th and 90th percentile of the value, the whiskers represent 5th and 95th. The scale of y-axis was log~10~-transformed.Fig. 2

Information about the recovery, MDL and MQL for the analytes in the blank matrix of serum and placenta samples were provided in [Table 1](#tbl1){ref-type="table"}.

Results of the wet-weight basis concentration of OCPs in samples were provided in [Table 2](#tbl2){ref-type="table"}.

Comparison of concentration levels in this dataset and previous researches were listed in [Table 3](#tbl3){ref-type="table"}.Table 3Comparison of OCP concentrations in different regions of the world; (median concentration, presented in ng g^−1^ lipid).Table 3Location of studynTotal DDXs*p,p\'*-DDT*p,p\'*-DDETotal HCHsβ-HCHRefs**Maternal SerumWuhan, China7933.20.2532.910.67.31**[@bib1]Shanghai, China102408\<LOD408138135[@bib3]Bristol, UK37411.031147.2[@bib4]Yancheng, China2477.4633327.3[@bib5]Taiyuan, China7126617.023173.9[@bib6]Korea14767.45.3163.48.577.91[@bib7]Spain30818.824325.4[@bib8]Delhi, India301.42.15.9[@bib9]**Cord SerumWuhan, China7932.20.2531.55.344.33**[@bib1]Shanghai, China102260\<LOD26010597[@bib3]Yancheng, China247\<LOD19313.3[@bib5]Taiyuan, China60169\<LOD14835.2[@bib6]Korea11764.663.38.475.42[@bib7]Spain30833.317516.9[@bib8]Delhi, India300.91.74.0[@bib9]**PlacentaWuhan, China7915.10.04615.17.593.25**[@bib1]Shanghai, China10245\<LOD432828[@bib3]Denmark4348.90.6647.212.09.67[@bib10]Finland4322.270.321.239.645.05[@bib10]Delhi, India301.93.98.5[@bib9]Korea10838.53.133.113.412.1[@bib7][^2]

The Pearson correlation analysis among three different human biological matrices were provided in [Table 4](#tbl4){ref-type="table"}.Table 4Pearson correlation of log-transformed concentration between maternal serum, cord serum and placenta samples.Table 4α-HCHβ-HCHγ-HCHδ-HCH*o,p\'-*DDE*p,p\'-*DDE*o,p\'-*DDD*p,p\'-*DDD*o,p\'-*DDT*p,p\'-*DDTMCMCMCMCMCMCMCMCMCMCLipid-weight based concentrationCn27384248425012321222β**.74**[b](#tbl4fnb){ref-type="table-fn"}**.98**[b](#tbl4fnb){ref-type="table-fn"}**.96**[b](#tbl4fnb){ref-type="table-fn"}**.70**[b](#tbl4fnb){ref-type="table-fn"}**.79**[b](#tbl4fnb){ref-type="table-fn"}**.94**[b](#tbl4fnb){ref-type="table-fn"}**.94**[b](#tbl4fnb){ref-type="table-fn"}**.97**[b](#tbl4fnb){ref-type="table-fn"}**.96**[b](#tbl4fnb){ref-type="table-fn"}**.87**[b](#tbl4fnb){ref-type="table-fn"}Pn323438384141475243524850261842389193335β.27.25**.96**[b](#tbl4fnb){ref-type="table-fn"}**.96**[b](#tbl4fnb){ref-type="table-fn"}**.54**[b](#tbl4fnb){ref-type="table-fn"}**.46**[b](#tbl4fnb){ref-type="table-fn"}**.34**[a](#tbl4fna){ref-type="table-fn"}**.39**[b](#tbl4fnb){ref-type="table-fn"}.28**.33**[a](#tbl4fna){ref-type="table-fn"}**.43**[b](#tbl4fnb){ref-type="table-fn"}**.50**[b](#tbl4fnb){ref-type="table-fn"}**.53**[b](#tbl4fnb){ref-type="table-fn"}**.88**[b](#tbl4fnb){ref-type="table-fn"}.15.02.40**.52**[a](#tbl4fna){ref-type="table-fn"}.06--.10Fresh-weight based concentrationCβ**.62**[b](#tbl4fnb){ref-type="table-fn"}**.97**[b](#tbl4fnb){ref-type="table-fn"}**.96**[b](#tbl4fnb){ref-type="table-fn"}**.71**[b](#tbl4fnb){ref-type="table-fn"}**.79**[b](#tbl4fnb){ref-type="table-fn"}**.92**[b](#tbl4fnb){ref-type="table-fn"}**.90**[b](#tbl4fnb){ref-type="table-fn"}**.96**[b](#tbl4fnb){ref-type="table-fn"}**.96**[b](#tbl4fnb){ref-type="table-fn"}**.84**[b](#tbl4fnb){ref-type="table-fn"}Pβ**.35**[a](#tbl4fna){ref-type="table-fn"}.26**.95**[b](#tbl4fnb){ref-type="table-fn"}**.94**[b](#tbl4fnb){ref-type="table-fn"}**.51**[b](#tbl4fnb){ref-type="table-fn"}**.40**[b](#tbl4fnb){ref-type="table-fn"}**.28**[a](#tbl4fna){ref-type="table-fn"}**.33**[a](#tbl4fna){ref-type="table-fn"}.23**.32**[a](#tbl4fna){ref-type="table-fn"}**.42**[b](#tbl4fnb){ref-type="table-fn"}**.49**[b](#tbl4fnb){ref-type="table-fn"}**.42**[a](#tbl4fna){ref-type="table-fn"}**.83**[b](#tbl4fnb){ref-type="table-fn"}.11--.00.34**.50**[a](#tbl4fna){ref-type="table-fn"}--.04--.12[^3][^4][^5]

The Pearson correlation coefficient (β) between the log-transformed concentrations of the chemicals and the sociodemographic characteristics of the participants in the maternal serum samples, cord serum sample and placenta samples for both lipid-adjusted concentration and wet-weight concentration were provided in [Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}, [Table 7](#tbl7){ref-type="table"}, respectively.Table 5Pearson correlation coefficient (β) between the log-transformed concentrations of the chemicals and the sociodemographic characteristics of the participants in the **maternal serum samples**.Table 5α-HCHβ-HCHγ-HCHδ-HCH*o,p'-*DDE*p,p'-*DDE*o,p'-*DDD*p,p'-*DDD*o,p'-*DDT*p,p'-*DDTLFLFLFLFLFLFLFLFLFLFPregnancy weight gain.21.26.00.02--.02--.01--.41[b](#tbl5fnb){ref-type="table-fn"}--.35[a](#tbl5fna){ref-type="table-fn"}--.35[a](#tbl5fna){ref-type="table-fn"}--.34[a](#tbl5fna){ref-type="table-fn"}.00.04--.08--.04--.11--.08.37.41.13.19Pre-pregnancy BMI--.24--.16.07.09.10.11.18.19.42[b](#tbl5fnb){ref-type="table-fn"}.44[b](#tbl5fnb){ref-type="table-fn"}.05.10.09.09--.07--.05.09.10--.18--.13Maternal age.00--.01--.13--.14.03.03--.17--.18.00.00--.01--.02.21.23.01.01--.31--.30.09.07Gestation period--.06--.12--.16--.19--.21--.23--.40[b](#tbl5fnb){ref-type="table-fn"}--.44[b](#tbl5fnb){ref-type="table-fn"}.01--.03--.04--.19.00--.06.27.25--.23--.27--.10--.16Occupation--.13--.07.00.01.25.27.24.26--.11--.09--.02--.02--.04.02.24.26.07.08--.19--.14Parity--.24--.17.13.14.30[a](#tbl5fna){ref-type="table-fn"}.31[a](#tbl5fna){ref-type="table-fn"}.03.06.07.09.17.17.02.00--.02--.01--.53[a](#tbl5fna){ref-type="table-fn"}--.55[a](#tbl5fna){ref-type="table-fn"}.27.28Abortion--.07--.05.09.09.16.17.08.10.04.06.00--.15--.08--.07--.09--.09--.44--.43.13.13Gestation conditions.06.16.14.16.01.02.03.10.00.04.19.24.13.17.09.10.38.42.10.15Vegetable.24.16--.06--.08--.17--.19--.11--.16.28.24--.09--.18--.18--.20--.22--.25.32.30--.20--.26Meat--.40[a](#tbl5fna){ref-type="table-fn"}--.29.12.15.12.16.30.35[a](#tbl5fna){ref-type="table-fn"}.14.19--.09.03.15.18--.02.01--.26--.25.02.09Seafood.00--.04--.16--.18.18.16.07.02--.01--.06.18.15--.34--.41[a](#tbl5fna){ref-type="table-fn"}.16.13.38.32--.08--.15Drinking water--.08--.15.01.00.12.11.11.09.32[a](#tbl5fna){ref-type="table-fn"}.32.29[a](#tbl5fna){ref-type="table-fn"}.29[a](#tbl5fna){ref-type="table-fn"}--.25--.26.00--.01.06.05.02--.01Tobacco smoking--.05.00.10.11.08.09--.04--.02--.08--.06.21.23.18.19.10.11^.^[c](#tbl5fnc){ref-type="table-fn"}^.^[c](#tbl5fnc){ref-type="table-fn"}.03.05Alcohol consuming--.05.00.10.11.13.14.00.03--.02.00.06.09^.^[c](#tbl5fnc){ref-type="table-fn"}^.^[c](#tbl5fnc){ref-type="table-fn"}.11.12^.^[c](#tbl5fnc){ref-type="table-fn"}^.^[c](#tbl5fnc){ref-type="table-fn"}.03.05Gender of infant--.23--.15--.23--.22--.14--.11.01.05--.01.00--.02--.04--.07--.06--.05--.03--.07--.03.06.10[^6][^7][^8][^9]Table 6Pearson correlation coefficient (β) between the log-transformed concentration of the chemicals and the sociodemographic characteristics of the participants in the **cord serum samples**.Table 6α-HCHβ-HCHγ-HCHδ-HCH*o,p'-*DDE*p,p'-*DDE*o,p'-*DDD*p,p'-*DDD*o,p'-*DDT*p,p'-*DDTLFLFLFLFLFLFLFLFLFLFPregnancy weight gain--.06--.11--.02--.03--.03--.04--.20--.22--.15--.17.07.05--.03--.07--.06--.07.14.12.12.10Pre-pregnancy BMI.06.09.13.14.39[b](#tbl6fnb){ref-type="table-fn"}.41[b](#tbl6fnb){ref-type="table-fn"}.04.04.35[b](#tbl6fnb){ref-type="table-fn"}.36[b](#tbl6fnb){ref-type="table-fn"}.13.13.26.23.15.16.02.02.06.07Maternal age.13.16--.15--.15.08.10--.11--.09--.05--.03.05.06.08.07--.18--.18--.45[b](#tbl6fnb){ref-type="table-fn"}--.45[b](#tbl6fnb){ref-type="table-fn"}--.15--.13Gestation period--.09--.13--.24--.25--.20--.22--.20--.22.01--.01--.21--.22--.08--.10.28.27--.11--.12--.04--.05Occupation--.07--.05--.01--.01.14.15--.09--.07--.08--.06.10.12.17.16.06.07.00.01--.06--.02Parity--.17--.16.22.21.22.23.19.17.04.03.04.04.22.16--.08--.09--.29--.30.00.01Abortion--.22--.23.16.15.09.09.21.21--.07--.07--.08--.08--.01--.01--.15--.17--.33[a](#tbl6fna){ref-type="table-fn"}--.34[a](#tbl6fna){ref-type="table-fn"}--.11--.12Gestation conditions.27.26.18.17.05.04.06.05.02.01.02.01.16.13.14.14.33[a](#tbl6fna){ref-type="table-fn"}.32[a](#tbl6fna){ref-type="table-fn"}.01--.02Vegetable.05--.02--.03--.05--.10--.13.00--.04.01--.02--.20--.22--.34--.39--.05--.07.01.00.08.06Meat--.07--.05.07.07.18.18.07.08.19.21.04.05.31.30--.12--.10--.06--.03--.15--.11Seafood--.20--.21--.13--.14.12.12.07.06--.10--.12.18.17--.13--.09.11.11.13.13.05.04Drinking water--.04--.07--.01--.02.17.15.12.09.11.09.16.13.10.07--.10--.11--.03--.04.03.01Tobacco smoking.09.05.14.13.08.09--.03--.02.00.01.18.18.21.19.11.10^.^[c](#tbl6fnc){ref-type="table-fn"}^.^[c](#tbl6fnc){ref-type="table-fn"}--.18--.14Alcohol consuming.09.05.14.13.08.07.02.00.03.02.06.04.21.19.11.10^.^[c](#tbl6fnc){ref-type="table-fn"}^.^[c](#tbl6fnc){ref-type="table-fn"}^.^[c](#tbl6fnc){ref-type="table-fn"}^.^[c](#tbl6fnc){ref-type="table-fn"}Gender of infant--.07--.02--.24--.23--.08--.06.10.13.01.03.02.05--.04--.02--.04--.02.08.10.22.27[^10][^11][^12][^13]Table 7Pearson correlation coefficient (β) between the log-transformed concentration of the chemicals and the sociodemographic characteristics of the participants in the **placenta samples**.Table 7α-HCHβ-HCHγ-HCHδ-HCH*o,p'-*DDE*p,p'-*DDE*o,p'-*DDD*p,p'-*DDD*o,p'-*DDT*p,p'-*DDTLFLFLFLFLFLFLFLFLFLFPregnancy weight gain.05.03.05.03.05.04--.10--.11--.09--.09.01.00--.07--.07.13.11.18.13--.01--.02Pre-pregnancy BMI.04--.01--.14--.16--.03--.05--.05--.09--.11--.13--.17--.18.22.16--.17--.19--.01--.01--.19--.20Maternal age.14.08--.14--.16--.07--.09--.12--.15--.06--.09--.16--.17.07.03--.03--.07--.20--.19--.13--.15Gestation period--.17--.19--.31[a](#tbl7fna){ref-type="table-fn"}--.32[a](#tbl7fna){ref-type="table-fn"}--.25--.26--.26--.28.01--.03--.20--.20--.13--.15--.12--.14--.25--.20--.12--.14Occupation--.06--.05--.03--.03--.05--.04.18.17--.06--.05--.11--.09.08.08.07.05--.18--.21--.10--.08Parity--.18--.22.10.05--.03--.07.13.08.00--.04--.04--.08.03--.03--.11--.13--.08--.13.01--.04Abortion--.29[a](#tbl7fna){ref-type="table-fn"}--.28.05.04--.18--.17.01.01--.05--.05--.21--.19--.14--.14--.15--.13--.35--.32--.11--.10Gestation conditions--.02.01.07.09.11.12--.02.01.13.14.04.06.24.24.07.09.06.09.23.23Vegetable.08.04.07.03.08.04.15.11.01--.03.14.10.03--.02.08.04.27.17.12.08Meat--.14--.19--.05--.09--.02--.06--.02--.07.09.04--.05--.09.08.03--.10--.14.01.00--.09--.13Seafood--.15--.10.00.02--.02.00--.01.01.11.12--.04--.01--.14--.09--.22--.16--.08--.02.03.06Drinking water.06.05--.03--.03.25.22.21.19.12.10.15.13.19.17--.06--.04.07.07.03.03Tobacco smoking--.11--.07.09.11.04.06.12.14.08.10.12.13.18.20--.03.00.09.12.03.06Alcohol consuming--.08--.05.05.06.01.03.00.02.07.08.05.06.14.16--.02.00.07.10.08.09Gender of infant--.25--.26[a](#tbl7fna){ref-type="table-fn"}--.25--.27[a](#tbl7fna){ref-type="table-fn"}--.24--.25.24.19.03--.01--.10--.12--.03--.09--.02--.05--.35[a](#tbl7fna){ref-type="table-fn"}--.39[a](#tbl7fna){ref-type="table-fn"}--.07--.10[^14][^15]

The Comparison of transplacental transfer ratio of the OCPs with previous published literatures were listed in [Table 8](#tbl8){ref-type="table"}.Table 8Comparison of transplacental transfer ratio with previous published literatures. (Median concentration and IQR, presented in ng g^−1^ lipid).Table 8Cord serum to maternal serum, (R~cm~, lipid adjusted)Placenta to maternal serum, (R~pm~, lipid adjusted),Cord serum to maternal serum, (R~cm~, fresh weight based)Location of the studynMedianIQRnMedianIQRMedianIQRβ-HCH380.63(0.48,0.79)380.39(0.26,0.51)0.21(0.16,0.30)Wuhan, China [@bib1]281.00(0.9,1.2)0.30(0.2,0.5)San Francisco, USA [@bib11]730.76(0.50,1.07)750.25(0.16,0.33)0.22(0.15,0.37)Shanghai, China [@bib3]2470.70(0.46,0.94)480.61(0.36,0.86)0.34(0.23,0.46)Spain [@bib8]1470.83[a](#tbl8fna){ref-type="table-fn"}------------Korea [@bib12]*p,p\'-*DDE501.07(0.95,1.19)480.48(0.29,0.77)0.38(0.33,0.48)Wuhan, China [@bib1]621.10(1.0,1.3)------0.40(0.3,0.5)San Francisco, USA [@bib11]860.66(0.43,0.89)830.13(0.07,0.21)0.23(0.13,0.33)Shanghai, China [@bib3]880.70(0.06,2.19)----------Thailand [@bib13]3040.34(0.11,0.58)490.17(0.09,0.23)0.68(0.52,0.84)Spain [@bib8]1471.13[a](#tbl8fna){ref-type="table-fn"}------------Korea [@bib12][^16][^17]

The Pearson correlation coefficients (β) between the log-transformed cord: maternal serum concentration ratios (R~cm~) of the chemicals and the sociodemographic characteristics of the participants in matched samples were provided in [Table 9](#tbl9){ref-type="table"}.Table 9Pearson correlation coefficients (β) between the log-transformed cord: maternal serum concentration ratios (R~cm~) of the chemicals and the sociodemographic characteristics of the participants in matched samples.Table 9α-HCHβ-HCHγ-HCHδ-HCH*o,p'-*DDE*p,p'-*DDE*o,p'-*DDD*p,p'-*DDD*o,p'-*DDT*p,p'-*DDTLFLFLFLFLFLFLFLFLFLFPregnancy weight gain--.22--.32--.23--.33[a](#tbl9fna){ref-type="table-fn"}.03--.06.03--.06.17.12.18--.01.14--.25.01--.09--.15--.37--.10--.21Pre-pregnancy BMI.56[b](#tbl9fnb){ref-type="table-fn"}.44[a](#tbl9fna){ref-type="table-fn"}--.18--.23.19.18--.14--.15.05.05--.01--.10--.23--.40.05--.01--.05--.30.11.05Maternal age.27.26.04.07.10.16--.05--.01--.06--.02.02.08--.33--.42--.09--.12.32.44--.17--.08Gestation period--.09--.07--.19--.05--.08--.02.05.05.20.23--.03.25.70[a](#tbl9fna){ref-type="table-fn"}.49--.02.05--.06.23.22.30Occupation--.08--.10.05.00--.14--.17--.26--.27.09.08.11.10--.17--.48.03--.02--.55--.45.05.07Parity.13.00.30.14.08.02.23.19.03.00--.31[a](#tbl9fna){ref-type="table-fn"}--.21.23.02.17.03.53.38--.29--.37Abortion--.15--.18.42[a](#tbl9fna){ref-type="table-fn"}.28.03.00.18.16.03.01--.34[a](#tbl9fna){ref-type="table-fn"}.12--.59--.35.11--.01.24.27.05--.03Gestation conditions.18--.02.16--.01--.19--.23.00--.09.09.03--.15--.26--.04--.12.19.16.16--.09.03--.17Vegetable--.43[a](#tbl9fna){ref-type="table-fn"}--.39[a](#tbl9fna){ref-type="table-fn"}.09.06.38[a](#tbl9fna){ref-type="table-fn"}.38[a](#tbl9fna){ref-type="table-fn"}--.06--.06--.07--.03--.12.07--.07--.36--.23--.16.14.18.13.25Meat.13.02--.11--.21--.10--.22--.03--.09.06.01--.05--.28.20--.11--.12--.22--.22--.05.22.19Seafood.04.07--.14--.05--.12--.08--.06--.02--.54[b](#tbl9fnb){ref-type="table-fn"}--.52[b](#tbl9fnb){ref-type="table-fn"}.09.09.46.53.16.25--.19.05.48[a](#tbl9fna){ref-type="table-fn"}.51[a](#tbl9fna){ref-type="table-fn"}Drinking water source.04.06--.12--.11.14.12--.02--.02--.15--.15--.25--.24--.11--.45--.14--.05.34.21--.06.01Tobacco smoking.12--.02.23.08.03.01.03.02.01.01--.08--.10-[c](#tbl9fnc){ref-type="table-fn"}-[c](#tbl9fnc){ref-type="table-fn"}.02--.10-[c](#tbl9fnc){ref-type="table-fn"}-[c](#tbl9fnc){ref-type="table-fn"}-[c](#tbl9fnc){ref-type="table-fn"}-[c](#tbl9fnc){ref-type="table-fn"}Alcohol consuming.12--.02.23.08--.13--.22.05--.02.02--.03--.07--.16-[c](#tbl9fnc){ref-type="table-fn"}-[c](#tbl9fnc){ref-type="table-fn"}.02--.10-[c](#tbl9fnc){ref-type="table-fn"}-[c](#tbl9fnc){ref-type="table-fn"}-[c](#tbl9fnc){ref-type="table-fn"}-[c](#tbl9fnc){ref-type="table-fn"}Gender of infant.07.04--.24--.18--.11--.15.18.20.13.15.06.16.55.53.04.02.22.35.10.11[^18][^19][^20][^21]

[Table 10](#tbl10){ref-type="table"}, [Table 11](#tbl11){ref-type="table"} provides the retention time along with the MS parameters for the quantitative and enantiomeric analysis.Table 10GC-EI-MS/MS MRM settings for targeted analytes in this dataset.Table 10AnalytesQuantifierQualifierRT (min)ParentProductCE (eV)ParentProductCE (eV)α-HCH2171815181145511.9β-HCH2171815181145512.4γ-HCH2171815181145512.6δ-HCH2171815181145513.1*o,p'-*DDE246176.230248176.23016.3*p,p'-*DDE246176.230248176.23017.1*o,p'-*DDD235165.230237165.22017.3*p,p'-*DDD235165.230237165.22018.1*o,p'-*DDT235165.230237165.22018.2*p,p'-*DDT235165.230237165.22019.1Table 11GC Retention time for chiral chemicals in this dataset.Table 11Analytes(+)-α-HCH(−)-α-HCH(+)-*o,p'*-DDD(−)-*o,p'*-DDD(−)-*o,p'*-DDT(+)-*o,p'*-DDTRetention Time (minute)19.320.256.857.262.563.1

Box-plots with dots representing the lipid adjusted concentration ratio of DDX metabolites (DDD + DDE) vs. the DDT parent compounds, and β-HCH vs. (α+γ)-HCH were provided in [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, respectively.

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Sample collection {#sec2.1}
----------------------

Matched maternal serum, cord serum and placenta samples from volunteering mothers (n = 79) and their infant was collected between November 2015 and March 2016 in Wuhan, China. Specific inclusion and exclusion criteria were applied in the baseline cohorts. Eligible mothers included those who are planning to deliver at Wuhan No.1 Hospital, with singleton pregnancy, and without apparent clinical symptoms during the gestation period.

The Maternal blood samples (n = 52) from pregnant women were collected within 3 days prior to delivery, and cord blood samples (n = 70) and placenta (n = 57) were collected at delivery following standard aseptic procedure [@bib14]. Most of the births were by vaginal delivery. Within all samples collected, there were 52 pairs of cord and maternal serum, 48 pairs of placenta and maternal serum, and 57 pairs of placenta and cord serum.

The serum sample was immediately separated by centrifugation at 5000 rpm for 10 min after the collection. The samples were frozen under −20 °C in clean glass containers until analysis.

Informed consent was given by all participants to collect the physical and sociodemographic data, including the maternal age, pregnancy weight gain, pre-pregnancy body mass index (BMI), parity, abortions, gestation conditions (hypertension and diabetes), drinking water source, habit in life (smoking tobacco and alcohol consuming), diet preferences (vegetables, meat or seafood), occupation of the mother and the gender and gestation period for the neonates. The ethical protocol was approved by the research ethics committee of Wuhan No.1 Hospital and Zhejiang University.

2.2. Instrumental analysis {#sec2.2}
--------------------------

### 2.2.1. Instrumental quantification of OCPs {#sec2.2.1}

Target chemicals were quantified with an Agilent 7890C-7010 gas chromatography-triple quadrupole mass spectrometry system (GC-MS/MS) in the electron ionization mode (EI mode). Compounds were separated on an HP-5ms Ultra Inert column (30 m × 0.25 mm × 0.25 μm, Agilent J&W, Agilent Inc. Palo Alto, CA, USA). The injector was set at the splitless injector mode at 230 °C and the volume was 2 μL. The initial oven temperature was 80 °C, increase at 10 °C min-1 to 180 °C, held for 5 min, then increase at 20 °C min^−1^ to 220 °C, and 5 °C min^−1^ to 245 °C. Total running time is 22 minutes. Carrier gas helium was set as constant flow at 1.0 mL min^−1^. Collision gas was nitrogen. The transfer line and the Extractor EI *Source* was set at 280 °C. The detector was set in the multiple reaction monitor (MRM) mode. Ion pairs were selected, and optimized collision energy were explored. The quantifier and qualifier, collision energy (CE) and retention time (RT) are shown in [Table 10](#tbl10){ref-type="table"}. The Retention time window was set at 0.5 minutes (−0.2 min to +0.3 min) of the reported retention time. The decimal of the mass in the MRM transitions were set according to Agilent manual, the width of the Quads (MS1 and MS2) were all set at UNIT (0.7 mass wide). The peak areas were acquired to quantify the wet-weight basis concentration in human biomatrices using Agilent Masshunter Workstation (ver. B7.01, Agilent Inc. Palo Alto, CA, USA).

### 2.2.2. Enantioselective analysis for chiral OCPs {#sec2.2.2}

The enantioselective analysis of chiral OCPs (α-HCH, o,p'-DDT and o,p'-DDD) enantiomers was analyzed on an Agilent 7890A-5975C GC-MS working under electron capture negative ion chemical ionization (NCI) mode. The enantiomers were separated on a BGB-172 chiral capillary column (30 m × 0.25 mm × 0.25 μm; BGB Analytik AG, Switzerland). The carrier gas was Helium at the flow rate of 1 mL min^−1^. *Regent* gas for CI operation was methane. Injector and detector temperatures were set at 250 °C and 230 °C, respectively. The injector was set at splitless mode, the injection volume is 2 μL. The initial oven temperature was set at 90 °C, hold for 1 min and then programmed at 20 °C min^−1^ to 160 °C, and 1 °C min^−1^ to 190 °C, which was held for 40 min, and finally increased to 225 °C at 25 °C min^−1^ for 40 min\'s hold. The detector set in a single ion monitor (SIM) mode. The retention times (RT) are shown in [Table 11](#tbl11){ref-type="table"}.

### 2.2.3. Lipid content in the samples {#sec2.2.3}

Total cholesterol (CHOL) and triglycerides (TG) were analyzed by a Beckman Coulter AU5800 Biochem analytic station in Wuhan 1st Hospital after the serum separation. Total lipids (TL) in the serum were used for normalizing the concentration of each pollutant. It was calculated as described previously [@bib15]: TL (g/l) = 1.12 × CHOL + 1.33 × TG + 1.48. The lipid weight of the placenta was determined gravimetrically [@bib16].

2.3. QA and QC {#sec2.3}
--------------

All labware used for the extraction was rinsed with hexane twice before the experiment. One procedure blank (hexane) was analyzed for each batch of samples (eight for serum, sixteen for placenta) to check for potential background contamination. The matrix spiked recovery was calculated by extracting the spiked matrix with three levels of the native standards spiking (20 ng mL^−1^, 5 ng mL^−1^, and 0.5 ng mL^−1^). Newborn calf serum and a pooled sample of 10 randomly selected placenta were chosen as the reference matrix for three different types of sample.

The method detection limit (MDL) and method quantification limit (MQL) were defined as the concentration that has 3 or 10 in the signal to noise ratio in the matrix, respectively. The concentrations lower than MDL were considered as not detected. All the concentrations reported in this dataset have already been corrected for the recovery. The calibration curve was prepared in a series of concentrations from 0.05 ng mL^−1^ to 500 ng mL^−1^, forced to pass through zero, the R^2^ \> 0.998.

The instrumental sensitivity was monitored by injecting a mixture of the native and surrogate standard at 5 ng mL^−1^ for every 20 samples.

2.4. Statistics {#sec2.4}
---------------

In this dataset, each data group were checked with Kolmogorov-Smirnov test for normal distribution. The concentration of target compound (Kolmogorov-Smirnov test, p \< 0.05) were then log-transformed to achieve normal distribution for further analysis.

The concentration in different human matrices from the sample volunteer were compared with Wilcoxon signed-rank test. The EF factor between two human matrices were compared with One-way ANOVA test. The difference between EF factors with racemic value was investigated using single sample *t*-test. The transfer ratio of same volunteers (R~pc~, R~pm~ and R~cm~) were compared using paired *t*-test.

The Pearson correlation test was used in this dataset to investigate the association among concentrations from different biomatrices and between the potential impact factors and the concentration/transfer efficiency.

The statistical significance was set at *p* \< 0.05. All above-mentioned statistics were done by IBM SPSS version 22 (Chicago, IL, USA).
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[^1]: TCMX was used as the IS in the experiment, the spike concentration was constant 50 ng in all extraction process in this part of the experiment.

[^2]: n: sample number. \<LOD: lower than limit of detection (LOD). Bold font markes the supported study by authors.

[^3]: M: maternal serum, C: cord serum, P: placenta. The correlation was only calculated when the concentration of the chemical was \>MDL in both samples. Bold font markes the significant correlations.

[^4]: Correlation is significant at the 0.05 level (2-tailed).

[^5]: Correlation is significant at the 0.01 level (2-tailed).

[^6]: L: Log-transformed lipid-based concentration, F: Log-transformed fresh-weight based concentration.

[^7]: Correlation is significant at the 0.05 level (2-tailed).

[^8]: Correlation is significant at the 0.01 level (2-tailed).

[^9]: Cannot be computed because at least one of the variables is constant.

[^10]: L: Log-transformed lipid-based concentration, F: Log-transformed fresh-weight based concentration.

[^11]: Correlation is significant at the 0.05 level (2-tailed).

[^12]: Correlation is significant at the 0.01 level (2-tailed).

[^13]: Cannot be computed because at least one of the variables is constant.

[^14]: L: Log-transformed lipid-based concentration, F: Log-transformed fresh-weight based concentration.

[^15]: Correlation is significant at the 0.05 level (2-tailed).

[^16]: n: sample number, IQR: inter-quartile range, from 25th percentile to 75th percentile.

[^17]: R~cm~ calculated from mean or median concentration, lipid-basis.

[^18]: L: Log-transformed lipid-based R~cm~ ratio, F: Log-transformed fresh-weight based R~cm~ ratio.

[^19]: Correlation is significant at the .05 level (2-tailed).

[^20]: Correlation is significant at the .01 level (2-tailed).

[^21]: Cannot be computed because at least one of the variables is constant.
